SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer (Q38745786)
Jump to navigation
Jump to search
scientific article published on 22 February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer |
scientific article published on 22 February 2016 |
Statements
1 reference
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer (English)
1 reference
1 reference
Julien Taieb
1 reference
Guy A van Hazel
1 reference
Volker Heinemann
1 reference
Navesh K Sharma
1 reference
Michael P N Findlay
1 reference
Jens Ricke
1 reference
David Perez
1 reference
Andrew H Strickland
1 reference
Tom Ferguson
1 reference
Javier Rodríguez
1 reference
Hendrik Kröning
1 reference
Ido Wolf
1 reference
Vinod Ganju
1 reference
Eveline Boucher
1 reference
Thomas Tichler
1 reference
Einat Shacham-Shmueli
1 reference
Alex Powell
1 reference
Paul Eliadis
1 reference
Richard Isaacs
1 reference
David Price
1 reference
Fred Moeslein
1 reference
Geoff Bower
1 reference
Val Gebski
1 reference
Mark Van Buskirk
1 reference
David N Cade
1 reference
Kenneth Thurston
1 reference
Peter Gibbs
1 reference
22 February 2016
1 reference
1 reference
34
1 reference
15
1 reference
1723-1731
1 reference
Identifiers
1 reference
1 reference